Matt Kann
About Matt Kann
Matt Kann is the Executive Director at BeiGene, with extensive experience in commercial learning and development in the oncology and hematology sectors.
Company
Matt Kann is currently working at BeiGene, where he holds the title of Executive Director. He has been with BeiGene since 2019, initially serving as Sr. Director, Commercial Learning and Development. His role is based in Half Moon Bay, California, United States, and he operates remotely.
Title
Matt Kann is the Executive Director at BeiGene. In this role, he is responsible for overseeing commercial operations training efforts and market access. He focuses on management and leadership development programs, tailoring solutions to meet the organization’s needs.
Previous Experience at Clovis Oncology
Prior to his current position, Matt Kann worked at Clovis Oncology as Director, Commercial Training and Development. His tenure lasted from 2018 to 2019, where he was based in Boulder, Colorado. In this role, he contributed to the training and development within the commercial sector of the company.
Experience in Oncology and Hematology
Matt Kann has amassed extensive experience in both oncology and hematology product training. Over his career, he has held various roles in related fields, demonstrating his expertise and commitment. His background includes positions at companies such as Genomic Health, Relypsa, Inc., and Onyx Pharmaceuticals.
Education and Expertise
Matt Kann studied at Stony Brook University, where he earned a BA in Psychology, Social Sciences Interdisciplinary, from 1985 to 1989. His education provided a strong foundation for his career in commercial training and development, particularly within the oncology sector.
Skills in Team Building and Root Cause Analysis
Matt Kann is known for his passion for solving commercial issues through root cause analysis. He focuses on building teams of talented individuals, fostering an environment where comprehensive solutions can be developed and implemented effectively. His leadership and analytical skills are integral to his role at BeiGene.